文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

实体器官移植受者艰难梭菌感染的发生率与结局

Incidence and Outcomes Associated With Clostridioides difficile Infection in Solid Organ Transplant Recipients.
PubMed 文献 · JAMA Netw Open · 2021-12-01
一句话结论安大略省实体器官移植受者中,每年队列的艰难梭菌感染发生率显著上升(2004年23.1/1000人年升至2017年46.7/1000人年,P=0.001),且晚发型感染与更高死亡风险相关(短期aOR 4.26,长期aHR 2.49)。

该研究基于加拿大安大略省2003年4月1日至2017年12月31日接受器官移植的10724例受者行政健康数据,随访至2020年3月31日,中位随访5.0年(61,987人年),726例(6.8%)因艰难梭菌感染住院。1年艰难梭菌感染发生率在年度队列中显著上升,从2004年的23.1/1000人年(95%CI 12.8-41.8)升至2017年的46.7/1000人年(95%CI 35.0-62.3),P=0.001。艰难梭菌感染与16.8%(n=122)的90天死亡率相关;在肾移植受者中,感染通常为晚发型(中位间隔2.2年,IQR 0.4-6.0)。需要透析的急性肾损伤与短期(aOR 1.86,95%CI 1.07-3.26)和长期(aHR 1.89,95%CI 1.29-2.78)死亡显著相关,晚发型感染也与更高的短期(aOR 4.26,95%CI 2.51-7.22)和长期(aHR 2.49,95%CI 1.78-3.49)死亡风险显著相关。作者认为预防策略不应仅限于移植后最初数月,针对急性肾损伤风险因素的综合治疗可能降低感染后短期和长期死亡率。

要点

  • 实体器官移植受者中,因艰难梭菌感染住院的比例为6.8%(726/10724),与16.8%(n=122)的90天死亡率相关。
  • 1年艰难梭菌感染发生率从2004年的23.1/1000人年(95%CI 12.8-41.8)升至2017年的46.7/1000人年(95%CI 35.0-62.3),P=0.001。
  • 晚发型艰难梭菌感染与更高的短期死亡风险(aOR 4.26,95%CI 2.51-7.22)和长期死亡风险(aHR 2.49,95%CI 1.78-3.49)显著相关。
  • 需要透析的急性肾损伤与短期死亡(aOR 1.86,95%CI 1.07-3.26)和长期死亡(aHR 1.89,95%CI 1.29-2.78)显著相关。
  • 在肾移植受者中,艰难梭菌感染通常为晚发型,中位间隔2.2年(IQR 0.4-6.0)。

适用人群与场景

  • 2003年4月1日至2017年12月31日在加拿大安大略省接受器官移植的所有居民,研究终点为2020年3月31日;共10724例受者,其中男性6901例(64.4%),中位年龄54岁(IQR 44-62),肾移植最常见(6453例,60.2%)。

研究设计与关键结果

  • 研究类型:基于行政健康数据的 population-based 队列研究;共纳入10724例实体器官移植受者,中位随访5.0年(IQR 2.3-8.8),61,987人年。
  • 主要结局:726例(6.8%)因艰难梭菌感染住院;1年艰难梭菌感染发生率在年度队列中显著上升,从2004年的23.1/1000人年(95%CI 12.8-41.8)升至2017年的46.7/1000人年(95%CI 35.0-62.3),P=0.001。
  • 次要结局:艰难梭菌感染与16.8%(n=122)的90天死亡率相关。
  • 在肾移植受者中,艰难梭菌感染通常为晚发型,中位间隔2.2年(IQR 0.4-6.0),与其他器官受者相比。
  • 需要透析的急性肾损伤与短期死亡显著相关(aOR 1.86,95%CI 1.07-3.26),与长期死亡显著相关(aHR 1.89,95%CI 1.29-2.78)。
  • 晚发型艰难梭菌感染与更高的短期死亡风险显著相关(aOR 4.26,95%CI 2.51-7.22),与更高的长期死亡风险显著相关(aHR 2.49,95%CI 1.78-3.49)。

证据类型、等级与局限

  • 证据类型:基于行政健康数据的 population-based 队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,预防策略不应仅限于移植后最初数月。
  • 作者认为,针对实体器官移植受者急性肾损伤风险因素的综合治疗可能降低艰难梭菌感染后短期和长期死亡率。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Little is known about the incidence and outcomes of Clostridioides difficile infection (CDI) in solid organ transplant (SOT) recipients.

OBJECTIVE: To estimate the CDI incidence and outcomes in SOT recipients.

DESIGN, SETTING, AND PARTICIPANTS: A population-based cohort study was conducted using administrative health care data for all Ontario, Canada, residents who received organ allografts from April 1, 2003, to December 31, 2017; March 31, 2020, was the end of the study period.

MAIN OUTCOMES AND MEASURES: The primary outcome was hospital admission with CDI diagnosis. The secondary outcomes included all-cause death, intensive care unit admission, acute kidney injury requiring dialysis, and fulminant CDI comprising any of the following: toxic megacolon, ileus, perforation, or colectomy. The association between short- vs long-term mortality (ie, death occurring within or after 90 days post-CDI) and the following variables was evaluated: age, sex, Deyo-Charlson Comorbidity Index, SOT type, early- vs late-onset CDI, fulminant CDI, intensive care unit admission, and acute kidney injury requiring acute dialysis.

RESULTS: Overall, 10 724 SOT recipients (6901 [64.4%] men; median age, 54 [IQR, 44-62] years) were eligible. Kidney transplant was the most common SOT type (6453 [60.2%]). The median follow-up time was 5.0 (IQR, 2.3-8.8) years, resulting in 61 987 person-years of follow-up. A total of 726 patients (6.8%) were hospitalized with CDI. The 1-year CDI incidence significantly increased in annual cohorts (ie, from 23.1; 95% CI, 12.8-41.8 per 1000 person-years in 2004 to 46.7; 95% CI, 35.0-62.3 per 1000 person-years in 2017; P = .001). Clostridioides difficile was associated with a 16.8% rate (n = 122) of 90-day mortality. In patients who underwent kidney transplant, CDI was typically late-onset (median interval, 2.2; IQR, 0.4-6.0 years) compared with recipients of other organs. Acute kidney injury requiring dialysis was significantly associated with short-term (adjusted odds ratio [aOR], 1.86; 95% CI, 1.07-3.26) and long-term (adjusted hazard ratio [aHR], 1.89; 95% CI, 1.29-2.78) mortality, and late-onset CDI was also significantly associated with a greater risk of short-term (aOR, 4.26; 95% CI, 2.51-7.22) and long-term (aHR, 2.49; 95% CI, 1.78-3.49) mortality.

CONCLUSIONS AND RELEVANCE: In this study, increasing CDI trends in annual cohorts of SOT recipients were observed. Posttransplant CDI was associated with mortality, and late-onset CDI was associated with a greater risk of death than early-onset CDI. These findings suggest that preventive strategies should not be limited to the initial months following transplantation. Comprehensive therapeutic approaches targeting acute kidney injury risk factors in SOT recipients may reduce short- and long-term post-CDI mortality.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Hosseini-Moghaddam SM, Luo B, Bota SE, et al. Incidence and Outcomes Associated With Clostridioides difficile Infection in Solid Organ Transplant Recipients. JAMA Netw Open. 2021. PMID: 34964852. doi:10.1001/jamanetworkopen.2021.41089

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。